These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 7053859

  • 21. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
    Brandes LJ, Bogdanovic RP, Cawker MD, LaBella FS.
    Cancer Res; 1987 Aug 01; 47(15):4025-31. PubMed ID: 2886214
    [Abstract] [Full Text] [Related]

  • 22. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P, Lykkesfeldt AE.
    Cancer Res; 1984 Mar 01; 44(3):1114-9. PubMed ID: 6362856
    [Abstract] [Full Text] [Related]

  • 23. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer.
    Leclercq G, Devleeschouwer N, Heuson JC.
    J Steroid Biochem; 1983 Jul 01; 19(1A):75-85. PubMed ID: 6887875
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
    Toko T, Shibata J, Nukatsuka M, Yamada Y.
    Cancer Chemother Pharmacol; 1997 Jul 01; 39(5):390-8. PubMed ID: 9054952
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ, Nelson K, Srinivasan S, Powell DE, Kenady DE, DePriest PD, Gallion HH, van Nagell JR.
    Cancer Res; 1992 Aug 01; 52(15):4106-12. PubMed ID: 1638522
    [Abstract] [Full Text] [Related]

  • 29. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E, Day BW.
    Anticancer Res; 1996 Aug 01; 16(3A):1107-15. PubMed ID: 8702221
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B, Happe HK.
    Endocrinology; 1986 Aug 01; 119(2):904-15. PubMed ID: 3732150
    [Abstract] [Full Text] [Related]

  • 31. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug 01; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines.
    Vessières A, Corbet C, Heldt JM, Lories N, Jouy N, Laïos I, Leclercq G, Jaouen G, Toillon RA.
    J Inorg Biochem; 2010 May 01; 104(5):503-11. PubMed ID: 20116857
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
    Gulino A, Pasqualini JR.
    Cancer Res; 1982 May 01; 42(5):1913-21. PubMed ID: 7066903
    [Abstract] [Full Text] [Related]

  • 38. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ, Murphy LC, Vrhovsek E, Sutherland RL, Lazarus L.
    Cancer Res; 1984 May 01; 44(5):1963-8. PubMed ID: 6324992
    [Abstract] [Full Text] [Related]

  • 39. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.
    J Steroid Biochem; 1983 Jul 01; 19(1A):59-68. PubMed ID: 6887873
    [Abstract] [Full Text] [Related]

  • 40. Binding characteristics of novel nonsteroidal antiestrogens to the rat uterine estrogen receptors.
    Martel C, Provencher L, Li X, St Pierre A, Leblanc G, Gauthier S, Mérand Y, Labrie F.
    J Steroid Biochem Mol Biol; 1998 Feb 01; 64(3-4):199-205. PubMed ID: 9605415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.